Date Filed | Type | Description |
04/21/2021 |
GN
| Enzo's Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization |
03/17/2021 |
GN
| ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM |
03/15/2021 |
GN
| Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates |
03/04/2021 |
GN
| Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference |
03/01/2021 |
GN
| Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15 |
02/03/2021 |
GN
| Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin |
01/20/2021 |
GN
| ENZO BIOCHEM'S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES |
01/04/2021 |
GN
| ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY'S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2 |
12/28/2020 |
GN
| ENZO RESPONDS AFTER REVIEWING THE POSITION OF INSTITUTIONAL SHAREHOLDER SERVICES |
12/15/2020 |
GN
| Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment |
12/09/2020 |
GN
| Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business Update |
12/02/2020 |
GN
| Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9 |
11/25/2020 |
GN
| ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS |
11/18/2020 |
GN
| Harbert Discovery Fund Issues Letter to Enzo Biochem Board of Directors |
11/18/2020 |
GN
| ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS |
10/27/2020 |
GN
| ENZO BIOCHEM LAUNCHES GOTESTMENOW™ ONLINE PLATFORM FOR CONSUMERS TO DIRECTLY ORDER COVID-19 LABORATORY TESTS |
10/13/2020 |
GN
| Enzo Biochem Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update |
10/06/2020 |
GN
| Enzo Biochem to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, October 13 |
07/21/2020 |
GN
| ENZO BIOCHEM TO PROVIDE ACCESS TO COVID-19 TESTING AT MORE THAN 50 NY PHARMACIES IN COLLABORATION WITH CPESN NY |
06/30/2020 |
GN
| Enzo Biochem to Provide COVID-19 Testing to Farmingdale State College Staff and Students as They Return to Campus |
06/23/2020 |
GN
| Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I |
06/08/2020 |
GN
| Enzo Biochem Reports Third Quarter 2020 Financial Results |
06/03/2020 |
GN
| Enzo Biochem to Announce Third Quarter 2020 Financial Results on Monday June 8, 2020 |
05/20/2020 |
GN
| Enzo Biochem Launches Proprietary Test for Detection of Coronavirus SARS-CoV-2 IgG Antibody Under FDA's Emergency Use Authorization |
05/12/2020 |
GN
| Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin |
04/29/2020 |
GN
| Enzo Announces Issuance of U.S. Patent for Methods of Using Proprietary Compound SK1-I in Patients; Exploring Options for Development as a Potential Treatment for COVID-19 |
04/24/2018 |
GN
| Report: Exploring Fundamental Drivers Behind Enzo Biochem, The Hackett Group, Rexford Industrial Realty, Green Plains, United Community Banks, and Encore Capital Group — New Horizons, Emerging Trends, and Upcoming Developments |
03/12/2018 |
BW
| Enzo Biochem Reports Second Quarter and First Half Results |
03/08/2018 |
BW
| Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 at 8:30 AM E.T. |
12/19/2017 |
GN
| Report: Exploring Fundamental Drivers Behind Allstate, Ashford Hospitality Prime, S&P Global, Enzo Biochem, Seres Therapeutics, and HFF — New Horizons, Emerging Trends, and Upcoming Developments |
12/07/2017 |
BW
| Enzo Biochem Reports Improved First Quarter Results |
12/05/2017 |
BW
| Enzo Biochem Schedules Teleconference to Discuss First Quarter 2018 Results Friday, December 8, 2017 at 8:30 AM E.T. |
09/27/2017 |
BW
| Enzo Biochem Reports Increase in Revenues and Profitable Fourth Quarter |
09/22/2017 |
BW
| Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter 2017 Results Thursday September 28, 2017 at 8:30 AM E.T. |
|